Identification of the Minimal Functional Unit in the Low Density Lipoprotein Receptor-related Protein for Binding the Receptor-associated Protein (RAP)
暂无分享,去创建一个
S. Moestrup | L. Christensen | O. Andersen | C. Jacobsen | E S Sørensen | E. Sørensen | O M Andersen | L L Christensen | P A Christensen | C Jacobsen | S K Moestrup | M Etzerodt | H C Thogersen | M. Etzerodt | H. Thøgersen | P. A. Christensen
[1] Deborah Fass,et al. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module , 1997, Nature.
[2] B. Hyman,et al. Expression of the Very Low‐Density Lipoprotein Receptor (VLDL‐r), an Apolipoprotein‐E Receptor, in the Central Nervous System and in Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[3] A. Schwartz,et al. Identification of Domains on the 39‐kDa Protein That Inhibit the Binding of Ligands to the Low Density Lipoprotein Receptor–Related Protein , 1993, Annals of the New York Academy of Sciences.
[4] D. Strickland,et al. The 39-kDa Receptor-associated Protein Modulates Lipoprotein Catabolism by Binding to LDL Receptors (*) , 1995, The Journal of Biological Chemistry.
[5] Peter Roepstorff,et al. Improved resolution and very high sensitivity in MALDI TOF of matrix surfaces made by fast evaporation , 1994 .
[6] M. Peitsch,et al. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. , 1997, Genomics.
[7] D. Decamp,et al. Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin. , 1998, Blood.
[8] K. Goto,et al. Human Apolipoprotein E Receptor 2 , 1996, The Journal of Biological Chemistry.
[9] N. Daly,et al. Three-dimensional structure of the second cysteine-rich repeat from the human low-density lipoprotein receptor. , 1995, Biochemistry.
[10] P. Bates,et al. Conversion of a human low-density lipoprotein receptor ligandbinding repeat to a virus receptor: identification of residues important for ligand specificity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[11] L. Ellgaard,et al. Dissection of the domain architecture of the alpha2macroglobulin-receptor-associated protein. , 1997, European journal of biochemistry.
[12] S. Moestrup,et al. Nested sets of protein fragments and their use in epitope mapping: characterization of the epitope for the S4D5 monoclonal antibody binding to receptor associated protein. , 1995, Journal of immunological methods.
[13] S. Moestrup,et al. The carboxy‐terminal domain of the receptor‐associated protein binds to the Vps10p domain of sortilin , 1998, FEBS letters.
[14] N. Tommerup,et al. Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein* , 1996, The Journal of Biological Chemistry.
[15] G. Bu,et al. Receptor-associated Protein Is a Folding Chaperone for Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.
[16] M. Jones,et al. Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA. , 1994, Human molecular genetics.
[17] S. Moestrup,et al. Alpha 2-macroglobulin-proteinase complexes, plasminogen activator inhibitor type-1-plasminogen activator complexes, and receptor-associated protein bind to a region of the alpha 2-macroglobulin receptor containing a cluster of eight complement-type repeats. , 1993, The Journal of biological chemistry.
[18] S. Moestrup,et al. The human alpha 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition. , 1990, Journal of Biological Chemistry.
[19] N. Daly,et al. Disulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domain. , 1995, Biochemistry.
[20] P. Gettins,et al. NMR Solution Structure of Complement-like Repeat CR8 from the Low Density Lipoprotein Receptor-related Protein* , 1999, The Journal of Biological Chemistry.
[21] T. Springer,et al. An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components. , 1998, Journal of molecular biology.
[22] S. Moestrup,et al. Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. , 1991, The Journal of biological chemistry.
[23] G. Bu,et al. The Domain Structure of Human Receptor-associated Protein , 1998, The Journal of Biological Chemistry.
[24] H. Vorum,et al. The receptor‐associated protein (RAP) binds calmodulin and is phosphorylated by calmodulin‐dependent kinase II. , 1996, The EMBO journal.
[25] E R Levy,et al. Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. , 1998, Biochemical and biophysical research communications.
[26] H. Geuze,et al. 39 kDa receptor‐associated protein is an ER resident protein and molecular chaperone for LDL receptor‐related protein. , 1995, The EMBO journal.
[27] B. Hyman,et al. Functional domains of the very low density lipoprotein receptor: molecular analysis of ligand binding and acid-dependent ligand dissociation mechanisms. , 1999, Journal of cell science.
[28] A. Soutar,et al. Expression in vitro of alternatively spliced variants of the messenger RNA for human apolipoprotein E receptor-2 identified in human tissues by ribonuclease protection assays. , 1999, European journal of biochemistry.
[29] M. Metzker,et al. Cloning of a novel member of the low-density lipoprotein receptor family. , 1998, Gene.
[30] G. Bu,et al. Differential Functions of Triplicated Repeats Suggest Two Independent Roles for the Receptor-associated Protein as a Molecular Chaperone* , 1997, The Journal of Biological Chemistry.
[31] S. Moestrup,et al. Evidence that the newly cloned low‐density‐lipoprotein receptor related protein (LRP) is the α2‐macroglobulin receptor , 1990, FEBS letters.
[32] D. Strickland,et al. Primary structure of alpha 2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. , 1991, The Journal of biological chemistry.
[33] S. Moestrup,et al. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. , 1993, The Journal of biological chemistry.
[34] A. Schwartz,et al. The Carboxyl-terminal Domain of Receptor-associated Protein Facilitates Proper Folding and Trafficking of the Very Low Density Lipoprotein Receptor by Interaction with the Three Amino-terminal Ligand-binding Repeats of the Receptor* , 1999, The Journal of Biological Chemistry.
[35] D. Russell,et al. Domain map of the LDL receptor: Sequence homology with the epidermal growth factor precursor , 1984, Cell.
[36] D. Weaver,et al. Molecular cloning and characterization of LR3, a novel LDL receptor family protein with mitogenic activity. , 1998, Biochemical and biophysical research communications.
[37] A. V. van Zonneveld,et al. Molecular Analysis of Ligand Binding to the Second Cluster of Complement-type Repeats of the Low Density Lipoprotein Receptor-related Protein , 1997, The Journal of Biological Chemistry.
[38] O. Myklebost,et al. Surface location and high affinity for calcium of a 500‐kd liver membrane protein closely related to the LDL‐receptor suggest a physiological role as lipoprotein receptor. , 1988, The EMBO journal.
[39] P. Rettenberger,et al. Ligand Binding Properties of the Very Low Density Lipoprotein Receptor , 1999, The Journal of Biological Chemistry.
[40] M. Larsson,et al. Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties. , 1996, European journal of biochemistry.
[41] M. Johnson,et al. Molecular Cloning of cDNA for Matriptase, a Matrix-degrading Serine Protease with Trypsin-like Activity* , 1999, The Journal of Biological Chemistry.
[42] P. Kroon,et al. Expression and disulfide‐bond connectivity of the second ligand‐binding repeat of the human LDL receptor , 1995, FEBS letters.
[43] S. Ebashi,et al. Detection of calcium binding proteins by 45Ca autoradiography on nitrocellulose membrane after sodium dodecyl sulfate gel electrophoresis. , 1984, Journal of biochemistry.
[44] H. Pannekoek,et al. Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor , 1998 .
[45] D. Strickland,et al. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. , 1994, The Journal of biological chemistry.
[46] M T Hearn,et al. 1,1'-Carbonyldiimidazole-mediated immobilization of enzymes and affinity ligands. , 1987, Methods in enzymology.
[47] N. Daly,et al. Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] E. Hochuli,et al. New metal chelate adsorbent selective for proteins and peptides containing neighbouring histidine residues. , 1987, Journal of chromatography.
[49] S. Moestrup,et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. , 1992, The Journal of biological chemistry.
[50] M. Llinás,et al. Domain Organization of the 39-kDa Receptor-associated Protein* , 1999, The Journal of Biological Chemistry.